Home › GLP-1 Medications › Oral Wegovy
Latest four-week snapshot through 2026-08-05 · 1 wave. Use the controls above to change the window.
GLP-1 Medications · 1 wave · n=72 answers, pooled
How often each assistant brings the brand up in recommendation answers.
| assistant | share of voice | answers |
|---|---|---|
| ChatGPT | 4% | 1 of 24 |
| Claude | 4% | 1 of 24 |
| Gemini | 0% | 0 of 24 |
Wave-by-wave share of recommendation answers that named this brand.
| wave | share of voice | answers | change |
|---|---|---|---|
| 2026-08-05 | 3% | 2 of 72 |
Recurring descriptions in the assistants' own words, grouped by theme.
“- Orforglipron at $149/month is cheaper than compounded semaglutide ever was; LillyDirect Zepbound at $299/month offers brand-name tirzepatide at a fraction of list price; and Oral Wegovy runs $199-299/month for a brand-name semaglutide pill.”
“- **Oral Wegovy** — launched in early January 2026, marking the first FDA-approved oral GLP-1 therapy specifically for chronic weight management in adults, approved December 22, 2025”
“The market has shifted with new competitively-priced FDA-approved drugs:”
“- **Oral Wegovy** — launched in early January 2026, marking the first FDA-approved oral GLP-1 therapy specifically for chronic weight management in adults, approved December 22, 2025”
“However, this comes with real trade-offs: while it tends to be more affordable than the brand-name, FDA-approved drugs, compounded semaglutide is not FDA-approved and is not usually covered by health insurance.”
“Ask about Foundayo or oral Wegovy”
“6% weight loss at $199–$299/month — a much cheaper cash-pay option than injectable Wegovy.”
“Oral Wegovy runs $199-299/month for a brand-name semaglutide pill”
“- **Refuse injections?** Ask about **Foundayo** or **oral Wegovy**.”
5 exact quoted mentions in this snapshot, grouped by coded tone.
“Oral Wegovy — launched in early January 2026, marking the first FDA-approved oral GLP-1 therapy specifically for chronic weight management in adults, approved December 22, 2025”
“Ask about Foundayo or oral Wegovy”
“Oral Wegovy runs $199-299/month for a brand-name semaglutide pill”
“Brand-name alternatives have become more affordable: Orforglipron at $149/month, LillyDirect Zepbound at $299/month, and Oral Wegovy at $199-299/month.”
“Oral Wegovy produces 16.6% weight loss at $199–$299/month — a much cheaper cash-pay option than injectable Wegovy.”
Which competitors assistants suggest when shoppers ask for something cheaper.
0 of 5 mentions appear alongside an identifiable web citation. Citation does not establish causation.
| cited source | mentions |
|---|
Method: fixed shopper questions asked repeatedly to Claude, OpenAI GPT and Gemini with web search on. Shares are the percentage of recommendation answers mentioning the brand. Quotes are AI outputs; full transcripts are kept as receipts.